Argonautica Private Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Sell
5,513
-625
-10% -$41.6K 0.09% 153
2026
Q1
$385K Buy
6,138
+49
+0.8% +$3.41K 0.12% 143
2025
Q4
$404K Sell
6,089
-330
-5% -$21.3K 0.12% 142
2025
Q3
$432K Buy
6,419
+476
+8% +$37.7K 0.13% 132
2025
Q2
$519K Sell
5,943
-15
-0.3% -$1.18K 0.16% 112
2025
Q1
$407K Buy
5,958
+182
+3% +$14.9K 0.14% 137
2024
Q4
$449K Sell
5,776
-540
-9% -$40K 0.15% 122
2024
Q3
$423K Buy
6,316
+22
+0.3% +$1.81K 0.14% 127
2024
Q2
$714K Hold
6,294
– – 0.24% 90
2024
Q1
$873K Buy
+6,294
New +$791K 0.31% 72

Other funds holding DXCM

Argonautica Private Wealth Management's DXCM Position: Q2 2026 in Review

Argonautica Private Wealth Management reduced its DexCom (DXCM) stake by 10% in Q2 2026, selling an estimated $41.6K and leaving 5,513 shares worth $371K. The position accounts for 0.09% of the portfolio, ranked #153.

Argonautica Private Wealth Management first reported a position in DXCM in Q1 2024 and has held it in 10 quarters since. The position peaked at $873K in Q1 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Argonautica Private Wealth Management held 5,513 shares of DexCom worth $371K as of Q2 2026.
  • Argonautica Private Wealth Management sold 625 DexCom shares in Q2 2026, an estimated $41.6K.
  • DexCom made up 0.09% of Argonautica Private Wealth Management's portfolio in Q2 2026, its #153 holding.
  • Argonautica Private Wealth Management first reported a position in DexCom in Q1 2024 and has held it in 10 quarters since.
  • Argonautica Private Wealth Management's DexCom position peaked at $873K in Q1 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Argonautica Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.